Saba Capital (GRX) boosts indirect stake with open-market share purchase

Rhea-AI Filing Summary

Saba Capital Management, L.P., a ten percent owner of Gabelli Healthcare & WellnessRx Trust (GRX), reported purchasing 200 shares of common stock on 2026-08-11 at $9.93 per share in an open market or private transaction. Following this indirect acquisition, Saba Capital’s reported holdings increased to 2,118,401 shares of GRX common stock.

Insider Trade Summary

Net Buyer: 200 shares

Net Buy 1 txn

Insider Saba Capital Management, L.P.

Role 10% Owner

Bought 200 shs ($2K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	200	$9.93	$2K

Holdings After Transaction: Common Stock — 2,118,401 shares (Indirect, -)

Key Figures

Shares purchased: 200 shares Purchase price: $9.93 per share Shares owned after transaction: 2,118,401 shares +1 more

4 metrics

Shares purchased 200 shares Common stock bought on 2026-08-11

Purchase price $9.93 per share Price for the 200-share common stock purchase

Shares owned after transaction 2,118,401 shares Indirect GRX common stock holdings following the purchase

Net buy shares reported 200 shares Net buy direction in the transaction summary

Key Terms

ten percent owner, indirect ownership, open market or private transaction

3 terms

ten percent owner regulatory

"The reporting person is identified as a ten percent owner of the issuer"

indirect ownership financial

"The filing classifies the holdings as indirect ownership using code I"

open market or private transaction financial

"Transaction code description notes a purchase in open market or private transaction"

FAQ

What did Saba Capital Management report in this Form 4 for GRX?

Saba Capital Management reported a purchase of 200 GRX common shares on 2026-08-11 at $9.93 per share, bringing its indirect holdings to 2,118,401 shares after the transaction.

How many Gabelli Healthcare & WellnessRx Trust (GRX) shares does Saba Capital now hold?

After the reported transaction, Saba Capital Management’s indirect holdings total 2,118,401 GRX common shares. This figure reflects the position following the 200-share purchase disclosed for the date 2026-08-11.

What was the price per share in Saba Capital’s latest GRX purchase?

Saba Capital Management paid $9.93 per share for 200 GRX common shares on 2026-08-11. The transaction is described as a purchase in open market or private transaction in the Form 4 filing.

Is Saba Capital a significant shareholder of GRX?

Yes. The Form 4 identifies Saba Capital Management as a ten percent owner of Gabelli Healthcare & WellnessRx Trust (GRX), with 2,118,401 common shares held indirectly after the reported 200-share purchase.

Was the GRX Form 4 transaction by Saba Capital a buy or sell?

The Form 4 reports a buy transaction by Saba Capital Management. It acquired 200 GRX common shares on 2026-08-11 at $9.93 per share, increasing its indirect ownership to 2,118,401 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/13/2026 - 12:49 PM Accepted by SEC EDGAR 08/13/2026 - 12:49 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Saba Capital Management, L.P.

(Last) (First) (Middle)

405 LEXINGTON AVENUE

58TH FLOOR

(Street)

NEW YORK NEW YORK 10174

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Gabelli Healthcare & WellnessRx Trust [ GRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/11/2026		P		200	A	$9.93	2,118,401	I	-

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Saba Capital Management, L.P. By: Zachary Gindes	08/13/2026
	Boaz Weinstein	08/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)